Center for Scientific Review; Notice of Closed Meetings, 11425-11426 [08-904]
Download as PDF
Federal Register / Vol. 73, No. 42 / Monday, March 3, 2008 / Notices
rmajette on PROD1PC64 with NOTICES
Contact Person: Kan Ma, PhD, Scientific
Review Administrator, NIH/NIAMS, EP
Review Branch, One Democracy Plaza, Suite
800, Bethesda, MD 20892–4872, 301–594–
4952, mak2@mail.NIH.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel, Small
Research Grants Review.
Date: March 25, 2008.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892.
Contact Person: Eric H. Brown, PhD,
Scientific Review Officer, National Institute
of Arthritis and Musculoskeletal Skin
Diseases, National Institutes of Health, 6701
Democracy Blvd, Room 824, MSC 4872,
Bethesda, MD 20892–4874, (301) 594–4955,
browneri@mail.nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel, Vascular
Diseases Clinical Trial.
Date: April 3, 2008.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Charles H. Washabaugh,
PhD, Scientific Review Administrator,
Review Branch, NIAMS/NIH, 6701
Democracy Blvd, Room 816, Bethesda, MD
20892, 301 451–4838,
washabac@mail.nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel,
Musculoskeletal Diseases Clinical Trial
Planning Grant.
Date: April 4, 2008.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference call).
Contact Person: Eric H. Brown, PhD,
Scientific Review Officer, National Institute
of Arthritis and Musculoskeletal Skin
Diseases, National Institutes of Health, 6701
Democracy Blvd, Room 824, MSC 4872,
Bethesda, MD 20892–4874, (301) 594–4955,
browneri@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: February 25, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–905 Filed 2–29–08; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005
15:33 Feb 29, 2008
Jkt 214001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute On Aging; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute on
Aging Special Emphasis Panel, March
10, 2008, 7 a.m. to March 11, 2008, 5
p.m., Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD
20817 which was published in the
Federal Register on February 4, 2008,
73 FR 6519.
Meeting will begin at 6 p.m. on March
10, 2008. The meeting is closed to the
public.
Dated: February 21, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–907 Filed 2–29–08; 8:45 am]
BILLING CODE 4140–01–M
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Services in Non-Specialty Setting.
Date: March 11, 2008.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Aileen Schulte, PhD,
Scientific Review Administrator, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6140, MSC 9608,
Frm 00045
Fmt 4703
Bethesda, MD 20892–9608, 301–443–1225,
aschulte@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
Dated: February 25, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–909 Filed 2–29–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
11425
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Hematology
Small Business.
Date: March 13–14, 2008.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Delia Tang, MD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4126, MSC 7802, Bethesda, MD
20892, 301–435–2506, tangd@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Drug Discovery.
Date: March 18, 2008.
Time: 1:30 p.m. to 3 p.m.
E:\FR\FM\03MRN1.SGM
03MRN1
rmajette on PROD1PC64 with NOTICES
11426
Federal Register / Vol. 73, No. 42 / Monday, March 3, 2008 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Marian Wachtel, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3208,
MSC 7858, Bethesda, MD 20892, 301–435–
1148, wachtelm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Immunology
Member Conflicts: Leukocytes, Lymphocytes,
and Inflammation.
Date: March 18, 2008.
Time: 1:30 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Stephen M. Niqida, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4212,
MSC 7812, Bethesda, MD 20892, 301–435–
1222, niqidas.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Endocrinology, Metabolism and
Reproductive Sciences.
Date: March 20, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Legacy Hotel and Meeting
Centre, 1775 Rockville Pike, Rockville, MD
20852.
Contact Person: Krish Krishnan, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6164,
MSC 7892, Bethesda, MD 20892, (301) 435–
1041, krishnak@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Special
Emphasis Panel for Member Conflict.
Date: March 24, 2008.
Time: 11:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Jose H. Guerrier, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, (301) 435–
1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, NAED
Reviewer Conflicts.
Date: March 26–27, 2008.
Time: 8 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Eduardo A. Montalvo,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5212,
VerDate Aug<31>2005
15:33 Feb 29, 2008
Jkt 214001
MSC 7852, Bethesda, MD 20892, (301) 435–
1168, montalve@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Lymphangiogenesis.
Date: March 31, 2008.
Time: 1:30 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Larry Pinkus, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4132,
MSC 7802, Bethesda, MD 20892, (301) 435–
1214, pinkus@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, AMCB,
ADDT, ACE and AIP Reviewer Conflicts.
Date: April 2–3, 2008.
Time: 8 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Eduardo A. Montalvo,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5212,
MSC 7852, Bethesda, MD 20892, (301) 435–
1168, montalve@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR 301–
368: MLPCN U02 Review Meeting.
Date: April 3–4, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Washington, DC,
1515 Rhode Island Avenue, NW.,
Washington, DC 20005.
Contact Person: Joseph G. Rudolph, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186,
MSC 7844, Bethesda, MD 20892, (301) 435–
2212, josephru@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.392–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
February 25, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–904 Filed 2–29–08; 8:45 am]
BILLING CODE 4140–01–M
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[FEMA–1745–DR]
Tennessee; Major Disaster and Related
Determinations
Federal Emergency
Management Agency, DHS.
ACTION: Notice.
AGENCY:
SUMMARY: This is a notice of the
Presidential declaration of a major
disaster for the State of Tennessee
(FEMA–1745–DR), dated February 7,
2008, and related determinations.
EFFECTIVE DATE: February 7, 2008.
FOR FURTHER INFORMATION CONTACT:
Peggy Miller, Disaster Assistance
Directorate, Federal Emergency
Management Agency, 500 C Street, SW.,
Washington, DC 20472, (202) 646–2705.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that, in a letter dated
February 7, 2008, the President declared
a major disaster under the authority of
the Robert T. Stafford Disaster Relief
and Emergency Assistance Act, 42
U.S.C. 5121–5206 (the Stafford Act), as
follows:
I have determined that the damage in
certain areas of the State of Tennessee
resulting from severe storms, tornadoes,
straight-line winds, and flooding during the
period of February 5–6, 2008, is of sufficient
severity and magnitude to warrant a major
disaster declaration under the Robert T.
Stafford Disaster Relief and Emergency
Assistance Act, 42 U.S.C. 5121–5206 (the
Stafford Act). Therefore, I declare that such
a major disaster exists in the State of
Tennessee.
In order to provide Federal assistance, you
are hereby authorized to allocate from funds
available for these purposes such amounts as
you find necessary for Federal disaster
assistance and administrative expenses.
You are authorized to provide Individual
Assistance and assistance for debris removal
and emergency protective measures
(Categories A and B) under the Public
Assistance program in the designated areas,
Hazard Mitigation throughout the State, and
any other forms of assistance under the
Stafford Act that you deem appropriate
subject to completion of Preliminary Damage
Assessments (PDAs), unless you determine
that the incident is of such unusual severity
and magnitude that PDAs are not required to
determine the need for supplemental Federal
assistance pursuant to 44 CFR 206.33(d).
Consistent with the requirement that
Federal assistance be supplemental, any
Federal funds provided under the Stafford
Act for Hazard Mitigation and Other Needs
Assistance will be limited to 75 percent of
the total eligible costs. Federal funds
provided under the Stafford Act for Public
Assistance also will be limited to 75 percent
E:\FR\FM\03MRN1.SGM
03MRN1
Agencies
[Federal Register Volume 73, Number 42 (Monday, March 3, 2008)]
[Notices]
[Pages 11425-11426]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 08-904]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Hematology Small Business.
Date: March 13-14, 2008.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Delia Tang, MD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4126, MSC 7802, Bethesda, MD 20892, 301-435-
2506, tangd@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Small Business: Drug Discovery.
Date: March 18, 2008.
Time: 1:30 p.m. to 3 p.m.
[[Page 11426]]
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Marian Wachtel, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3208, MSC 7858, Bethesda, MD 20892, 301-435-
1148, wachtelm@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Immunology Member Conflicts: Leukocytes, Lymphocytes, and
Inflammation.
Date: March 18, 2008.
Time: 1:30 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Stephen M. Niqida, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4212, MSC 7812, Bethesda, MD
20892, 301-435-1222, niqidas.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Endocrinology, Metabolism and Reproductive Sciences.
Date: March 20, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: The Legacy Hotel and Meeting Centre, 1775 Rockville Pike,
Rockville, MD 20852.
Contact Person: Krish Krishnan, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6164, MSC 7892, Bethesda, MD 20892, (301) 435-
1041, krishnak@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Special Emphasis Panel for Member Conflict.
Date: March 24, 2008.
Time: 11:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Jose H. Guerrier, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD
20892, (301) 435-1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, NAED Reviewer Conflicts.
Date: March 26-27, 2008.
Time: 8 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Eduardo A. Montalvo, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5212, MSC 7852, Bethesda, MD
20892, (301) 435-1168, montalve@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Lymphangiogenesis.
Date: March 31, 2008.
Time: 1:30 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Larry Pinkus, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4132, MSC 7802, Bethesda, MD 20892, (301) 435-
1214, pinkus@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, AMCB, ADDT, ACE and AIP Reviewer Conflicts.
Date: April 2-3, 2008.
Time: 8 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Eduardo A. Montalvo, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5212, MSC 7852, Bethesda, MD
20892, (301) 435-1168, montalve@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, PAR 301-368: MLPCN U02 Review Meeting.
Date: April 3-4, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Washington, DC, 1515 Rhode Island
Avenue, NW., Washington, DC 20005.
Contact Person: Joseph G. Rudolph, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186, MSC 7844, Bethesda, MD
20892, (301) 435-2212, josephru@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.392-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
February 25, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-904 Filed 2-29-08; 8:45 am]
BILLING CODE 4140-01-M